Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members

From a Breast Cancer Nurse to a Patient with Metastatic Breast Cancer
Idalina Colburn, BSN, RN, OCN, ONN-CG, recounts her transition from helping people with cancer as an oncology nurse to being a patient herself and learning to appreciate every moment of her life. Read More ›

Cancer: Awful and Amazing
Gina Stratton was inspired by her granddad, who had advanced-stage lung cancer. She talks about her dealing with her breast cancer diagnosis at the age of 40 while having a full-time job. Read More ›

Breast Cancer Treatments

Immunotherapy for the Management of Triple-Negative Metastatic Breast Cancer

Genetic Predisposition to Breast Cancer: Moving from “Why Me?” to “What’s Next?”

Caring for the Breast Cancer Family Caregiver

5 Questions to Ask Yourself
A cancer diagnosis will probably cause you to pause and reflect on your life. Here are 5 questions to ask yourself. Read More ›

Tukysa Improves Survival in Patients with HER2-Positive Breast Cancer that Has Spread to the Brain
The new cancer drug Tukysa (tucatinib), when given in combination with Herceptin (trastuzumab) and capecitabine, dramatically improved outcomes for patients with HER2-positive advanced breast cancer that has spread to the brain, according to data presented by Nancy U. Lin, MD, Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, at the 2020 ASCO annual meeting. Read More ›

Adding Kisqali to Endocrine Therapy Increases Survival in Patients with Advanced Breast Cancer and Visceral Metastases
Metastatic breast cancer is cancer that has spread beyond the breast to other parts of the body. Visceral metastases refer to cancer that has spread to the internal organs of the body, specifically those within the chest (such as the heart or lungs) or abdomen (such as the liver, pancreas, or intestines). Read More ›

Piqray plus Faslodex Effective in HR-Positive Advanced Breast Cancer with PIK3CA Mutation After Endocrine and Targeted Therapy
Induction treatment with endocrine and targeted therapies has significantly improved survival for patients with hormone receptor (HR)-positive advanced breast cancer, but over time almost all patients stop responding to therapy. Read More ›

Page 9 of 19